CMN 552 MODULE 4 EXAM COMPLETE TEST
PAPER WITH CORRECT ANSWERS
◉ What treatment has demonstrated efficacy for social anxiety
disorder?
Answer: Cognitive-behavioral therapy (CBT).
◉ What are the first-line pharmacologic treatments for social
anxiety disorder?
Answer: Serotonergic agents, with beta blockers used for the
performance subtype.
◉ What is the typical course of social anxiety disorder?
Answer: It is a chronic condition with a high rate of symptom re-
emergence after remission.
◉ What differentiates agoraphobia from social anxiety disorder?
Answer: Agoraphobia involves fear of panic or shame in public
situations, while social anxiety disorder involves fear of being
judged.
◉ What is the prevalence of comorbid depressive disorders in
patients with agoraphobia?
,Answer: 33 to 52 percent.
◉ What is a common confusion in diagnosing agoraphobia?
Answer: It can be confused with social anxiety disorder or PTSD due
to context-dependent fears.
◉ What is the typical duration for a specific phobia to be diagnosed?
Answer: Longer than 6 months.
◉ What is the significance of the DSM-5's recognition of
agoraphobia without panic disorder?
Answer: It encourages clinicians to screen for agoraphobia more
frequently.
◉ What is a common characteristic of patients with specific
phobias?
Answer: They often have multiple phobic stimuli, each coded
separately.
◉ What is the impact of parenting styles on the familial risk of social
anxiety disorder?
Answer: Parenting styles may contribute to the familial risk,
although specific genetic factors are not well understood.
,◉ What environmental factors may contribute to phobias?
Answer: Trauma and conditioning.
◉ What is the treatment of choice for Specific Phobia?
Answer: Behavioral therapy series that includes exposure-based,
systematic desensitization.
◉ What insight do patients with Specific Phobia often recognize?
Answer: Their anxiety exceeds the true threat of the stimulus.
◉ What is the lifetime prevalence rate of Generalized Anxiety
Disorder (GAD)?
Answer: 5 percent.
◉ What age group commonly begins to experience GAD?
Answer: Late teens.
◉ Which gender is more commonly affected by GAD?
Answer: Women.
◉ What are common comorbidities associated with GAD?
, Answer: Other anxiety spectrum disorders and substance use
disorders.
◉ What significant change occurred in the DSM-5 regarding
Separation Anxiety Disorder?
Answer: Removal of the age-of-onset restriction.
◉ What is a prominent symptom of Separation Anxiety Disorder?
Answer: Worry.
◉ What is the relationship between anxiety disorders and physical
conditions?
Answer: Anxiety disorders have a high magnitude of comorbidity
with several medical conditions.
◉ What was found in the Australian National Survey of Health and
Wellbeing regarding anxiety disorders?
Answer: There were two-fold greater rates of physical conditions
among those with anxiety disorders.
◉ How do comorbid anxiety and physical disorders affect disability?
Answer: They are associated with substantially greater disability
than anxiety disorders alone.
PAPER WITH CORRECT ANSWERS
◉ What treatment has demonstrated efficacy for social anxiety
disorder?
Answer: Cognitive-behavioral therapy (CBT).
◉ What are the first-line pharmacologic treatments for social
anxiety disorder?
Answer: Serotonergic agents, with beta blockers used for the
performance subtype.
◉ What is the typical course of social anxiety disorder?
Answer: It is a chronic condition with a high rate of symptom re-
emergence after remission.
◉ What differentiates agoraphobia from social anxiety disorder?
Answer: Agoraphobia involves fear of panic or shame in public
situations, while social anxiety disorder involves fear of being
judged.
◉ What is the prevalence of comorbid depressive disorders in
patients with agoraphobia?
,Answer: 33 to 52 percent.
◉ What is a common confusion in diagnosing agoraphobia?
Answer: It can be confused with social anxiety disorder or PTSD due
to context-dependent fears.
◉ What is the typical duration for a specific phobia to be diagnosed?
Answer: Longer than 6 months.
◉ What is the significance of the DSM-5's recognition of
agoraphobia without panic disorder?
Answer: It encourages clinicians to screen for agoraphobia more
frequently.
◉ What is a common characteristic of patients with specific
phobias?
Answer: They often have multiple phobic stimuli, each coded
separately.
◉ What is the impact of parenting styles on the familial risk of social
anxiety disorder?
Answer: Parenting styles may contribute to the familial risk,
although specific genetic factors are not well understood.
,◉ What environmental factors may contribute to phobias?
Answer: Trauma and conditioning.
◉ What is the treatment of choice for Specific Phobia?
Answer: Behavioral therapy series that includes exposure-based,
systematic desensitization.
◉ What insight do patients with Specific Phobia often recognize?
Answer: Their anxiety exceeds the true threat of the stimulus.
◉ What is the lifetime prevalence rate of Generalized Anxiety
Disorder (GAD)?
Answer: 5 percent.
◉ What age group commonly begins to experience GAD?
Answer: Late teens.
◉ Which gender is more commonly affected by GAD?
Answer: Women.
◉ What are common comorbidities associated with GAD?
, Answer: Other anxiety spectrum disorders and substance use
disorders.
◉ What significant change occurred in the DSM-5 regarding
Separation Anxiety Disorder?
Answer: Removal of the age-of-onset restriction.
◉ What is a prominent symptom of Separation Anxiety Disorder?
Answer: Worry.
◉ What is the relationship between anxiety disorders and physical
conditions?
Answer: Anxiety disorders have a high magnitude of comorbidity
with several medical conditions.
◉ What was found in the Australian National Survey of Health and
Wellbeing regarding anxiety disorders?
Answer: There were two-fold greater rates of physical conditions
among those with anxiety disorders.
◉ How do comorbid anxiety and physical disorders affect disability?
Answer: They are associated with substantially greater disability
than anxiety disorders alone.
